Validity of LIDAS (LIfetime Depression Assessment Self-report): a self-report online assessment of lifetime major depressive disorder.

BACKGROUND: There is a paucity of valid, brief instruments for the assessment of lifetime major depressive disorder (MDD) that can be used in, for example, large-scale genomics, imaging or biomarker studies on depression. We developed the LIfetime Depression Assessment Self-report (LIDAS), which assesses lifetime MDD diagnosis according to DSM criteria, and is largely based on the widely used Composite International Diagnostic Interview (CIDI). Here, we tested the feasibility and determined the sensitivity and specificity for measuring lifetime MDD with this new questionnaire, with a regular CIDI as reference. METHOD: Sensitivity and specificity analyses of the online lifetime MDD questionnaire were performed in adults with (n = 177) and without (n = 87) lifetime MDD according to regular index CIDIs, selected from the Netherlands Study of Depression and Anxiety (NESDA) and Netherlands Twin Register (NTR). Feasibility was tested in an additional non-selective, population-based sample of NTR participants (n = 245). RESULTS: Of the 753 invited persons, 509 (68%) completed the LIDAS, of which 419 (82%) did this online. User-friendliness of the instrument was rated high. Median completion time was 6.2 min. Sensitivity and specificity for lifetime MDD were 85% [95% confidence interval (CI) 80-91%] and 80% (95% CI 72-89%), respectively. This LIDAS instrument gave a lifetime MDD prevalence of 20.8% in the population-based sample. CONCLUSIONS: Measuring lifetime MDD with an online instrument was feasible. Sensitivity and specificity were adequate. The instrument gave a prevalence of lifetime MDD in line with reported population prevalences. LIDAS is a promising tool for rapid determination of lifetime MDD status in large samples, such as needed for genomics studies.

Evaluation of the Abraxis Strip Test for Microcystins™ for use with wastewater effluent and reservoir water.

Rapid tests for the microcystin-type cyanobacterial toxins that are designed to be able to be used in the field have recently become available. The tests provide a semi-quantitative result over a relatively narrow concentration range (10-fold) and are available with detection limits relevant for drinking water and recreational water compliance testing (1 µg/L and 10 µg/L, respectively). The aim of this research was to assess the applicability of these tests for the determination of microcystin-related toxicity in treated effluent from the Western Treatment Plant and potable source water from Tarago Reservoir, both near Melbourne, Australia. Accuracy, precision, cross-reactivity, matrix effects and inter-operator variability were assessed. The claimed mLR concentration response range of the tests was confirmed within reasonable limits, although the false negative and false positive rates were significant for spike concentrations below 2.5 µg/L (Recreational Strip Test). Inter-operator variability was reasonably high (CV=23%) and this was exacerbated by the use of untrained scorers. Contributing to this was significant inter-assay variability in test band intensity (CV=28%). The strip tests responded to all 8 microcystin analogues tested and also to a mixture of another 7 analogues contained in a Certified Bloom Material. Cross-reactivity was always greater than 50%. Matrix effects due to the test waters or to cyanobacterial cell material were also relatively minor, being of the order of 2-fold at the maximum. Overall, these Strip Tests were found to be reliable for relatively rapid detection of microcystins around the upper limits of their response ranges, as recommended by the manufacturer. While the Recreational Water Strip test was less reliable in the lower ranges, it can be used in conjunction with the Drinking Water Strip test to reduce uncertainty around the 1 µg/L concentration. Despite limitations, both strip tests provide near real-time information which can assist with day to day operational decisions. When results indicate microcystin concentrations near compliance limits it is recommended that use of the test kits should be supported by accurate quantitative toxin testing together with traditional algal cell counts, and possibly emerging qPCR methods for species and toxin gene detection.

Limited uptake of the cyanobacterial toxin cylindrospermopsin by Vero cells.

Cylindrospermopsin (CYN) is a cyanobacterial toxin increasingly found in drinking water sources worldwide. Toxicity studies have shown CYN can induce effects in a range of different cell types with primary hepatocytes consistently shown to be the most sensitive cellular model. How CYN enters the intracellular environment is not clear, although the size and hydrophilic nature of the toxin suggest it would not readily cross a lipid bilayer. In this study, a Vero cell line expressing green fluorescent protein (GFP) was used to monitor for CYN uptake based on the toxin's potent effects on protein synthesis. Effects on the GFP signal were compared with inhibitors cycloheximide (CHEX) and emetine. While CYN potency was demonstrated in a cell-free system (CYN>CHEX>emetine) it was considerably reduced in the Vero-GFP cell model (CHEX, emetine>>CYN). In contrast to other inhibitors, CYN effects on GFP signal increased 6 fold over 4-24 h incubation indicating slow, progressive uptake of the toxin. Confirming that the uptake process is not energy dependent CYN entry also occurred at 4 degrees C, while competition experiments excluded the uracil nucleobase transporter system as potential mechanism for CYN uptake. Dilution of media enhanced CYN uptake by Vero-GFP cells although mechanism by which this occurred is unknown.